Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1738536

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1738536

Global Quinine Sulphate Market Size By Type, By Application, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF & Excel (5 User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Quinine Sulphate Market Size And Forecast

Quinine Sulphate Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2026 to 2032.

Rising awareness about health among the peoples because of the rising concerns in health leads to drives the market of Quinine Sulphate. Further rise in consumption of tonic water can drive the Quinine Sulphate Market during the forecast period. In addition increase, the use of Quinine Sulphate in the healthcare sector will propel market growth. The Global Quinine Sulphate Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Quinine Sulphate Market Definition

Quinine sulphate is used to treat malaria and babesiosis. This includes the treatment of malaria due to Plasmodium falciparum that is resistant to chloroquine when artesunate is not available. An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug and is the active ingredient in extracts of the cinchona. Quinine sulphate is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It is also helpful in getting rid of muscular disorders, especially nocturnal leg cramps and myotonia congenita because it directly affects the muscle membrane and sodium channels. Although, the U.S.

Food and Drug Administration has approved it only for curing malaria, but doctors can legally prescribe this medication for any type of treatment they find it appropriate for. Quinine sulphate inhibits nucleic acid synthesis, protein synthesis, and glycolysis in Plasmodium falciparum and can bind with hemozoin in parasitized erythrocytes. Quinine Sulphate occurs as a white crystalline powder that becomes darker when comes in light. The Quinine Sulphate tastes bitter and it is odourless also it is soluble in water, chloroform, alcohol, and ether. To soften the taste sugar and other flavours are added with Quinine Sulphate.

Global Quinine Sulphate Market Overview

For the treatment of leg cramps, Quinine sulphate is majorly used especially in older patients which propels the demand for Quinine sulphate in many countries. Further Quinine sulphate has a scientific use as the chiral moiety for the ligands used in Sharpless asymmetric dihydroxylation as well as for numerous other chiral catalyst backbones that can drive the market.

In addition, Quinine sulphate is a relatively constant and well-known fluorescence quantum yield, Quinine is used in photochemistry as a common fluorescence standard this can propel the growth of the market. Quinine is a flavor component of tonic water and bitter lemon drink mixers. On the soda gun behind many bars, this can expect a significant growth during the forecast period. However, many countries like the U.S, U.K have banned Quinine sulphate to treat malaria which can hamper the growth of the market.

Global Quinine Sulphate Market: Segmentation Analysis

The Global Quinine Sulphate Market is Segmented based on Type, Application, and Geography.

Quinine Sulphate Market, By Type

200mg

300mg

  • Other

Based on Type, the market is bifurcated into 200mg. 300mg and other. The recommended dose of Quinine sulphate is 200 mg at bedtime and the maximum dose is 300 mg.

Quinine Sulphate Market, By Application

  • Malaria
  • Problematic Leg Cramps
  • Other
  • Based on Application, the market is bifurcated into malaria, problematic leg cramps, and other. Mostly Quinine sulphate is used to treat problematic leg cramps. Quinine Sulphate at a dose of 200-300 mg was used for many years to treat nocturnal leg cramps. Usually idiopathic, these muscle cramps are common, particularly in older patients. Quinine may help by decreasing the excitability of the motor end-plate and increasing the muscle refractory period

Quinine Sulphate Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of regional analysis, the Global Quinine Sulphate Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Asia Pacific expected significant growth of Quinine Sulphate Market during the forecast period.

Key Players

The "Global Quinine Sulphate Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Actavis, Wockhardt, Shreeji Pharma International, A. B. Enterprises, Caraco Pharmaceutical Laboratories, Aecochem Corp, Hangzhou Dayang Co. Ltd., Haihang Industry Co. Ltd., Trademax Pharmaceuticals & Chemicals and IS Chemical Technology Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Product Code: 60303

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL QUININE SULPHATE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL QUININE SULPHATE MARKET, OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL QUININE SULPHATE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 200mg
  • 5.3 300mg
  • 5.4 Other

6 GLOBAL QUININE SULPHATE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Malaria
  • 6.3 Problematic Leg Cramps
  • 6.4 Other

7 GLOBAL QUININE SULPHATE MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL QUININE SULPHATE MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Actavis
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Wockhardt
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Shreeji Pharma International
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 A. B. Enterprises
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Caraco Pharmaceutical Laboratories
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Aecochem Corp
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Hangzhou Dayang Co., Ltd.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Haihang Industry Co., Ltd.
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Trademax Pharmaceuticals & Chemicals
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 IS Chemical Technology Ltd.
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!